Wordt geladen...
Customized chemotherapy in metastatic non-small cell lung cancer (NSCLC)
Metastatic non-small cell lung cancer (NSCLC) unfortunately remains a lethal disease, despite recent genetic characterization of subclasses of NSCLC, mainly adenocarcinoma, which has led to the development of targeted therapies that improve progression-free survival (PFS). Ultimately, however, patie...
Bewaard in:
| Gepubliceerd in: | Transl Lung Cancer Res |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Pioneer Bioscience Publishing Company
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4367603/ https://ncbi.nlm.nih.gov/pubmed/25806231 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2013.02.03 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|